Estats Units - anglès - NLM (National Library of Medicine)

carilion materials management - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - pindolol tablets are indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. pindolol tablets are contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings.)

Estats Units - anglès - NLM (National Library of Medicine)

carilion materials management - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - pindolol tablets are indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. pindolol tablets are contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings.)

Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - pindolol - white tablet, diameter: 7.0 mm, thickness: 2.4 mm

Estats Units - anglès - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - tablet - 5 mg - visken® (pindolol) is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. visken® (pindolol) is contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings)

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pindolol -

Filipines - anglès - FDA (Food And Drug Administration)

novartis healthcare phils inc - pindolol - tablet - 5mg

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pindolol, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica - indications as at 18 november 2004: hypertension (either alone or in combination with other antihypertensive drugs). angina pectoris (prevention of attacks). cardiac arrhythmias [sinus tachycardia, paroxysmal tachycardia, supraventricular and ventricular extrasystoles, drug induced extrasystoles (digitalis), atrial flutter and fibrillation - to slow the ventricular rate]. functional hyperadrenergic cardiac disturbances (hyperkinetic heart syndrome, neurocirculatory asthenia).

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - pindolol 5 mg - tablet - 5 mg - pindolol 5 mg - pindolol

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pindolol -

Canadà - anglès - Health Canada

xediton pharmaceuticals inc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents